Views & Analysis Living with DMD: Inspiring each other’s futures Diagnosed with Duchenne muscular dystrophy (DMD) at three years old, Dr Jon Hastie grew up n
News Drug price controversies hit pharma's reputation Patient groups slam pharma over drug costs in latest survey.
Patients LSX2026: On promise and patience, with Hans Schambye At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
